Skip to content
DETOUR
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
DETOUR
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
Search
Read about Endologix
in the news
Embrace the evidence.
2021 News
Archives
All
2026
2025
2024
2023
2022
2021
Nov 23
Endologix Announces Completion of Enrollment in the TORUS 2 Study for PAD in SFA
Nov 10
Endologix Names Dr. Matthew Thompson President and CEO
Sep 29
Endologix Initiates Randomized Study of ALTO® Abdominal Stent Graft System
Jul 19
Endologix LLC Receives FDA Breakthrough Device Designation for ChEVASTM System
May 11
Endologix LLC Announces Launch of ALTO® Abdominal Stent Graft System in Canada and Argentina Company Expands Global Reach with Latest Endovascular Aneurysm Repair (EVAR) Technology
Previous
Page
1
Page
2
Next
